Skip to main content

Affording therapy.

We believe that everyone who is prescribed growth hormone therapy should have access to it. We have developed several programs that may help.

JumpStart™

Getting started and staying on therapy.

Sometimes insurance coverage takes time to kick in. This can happen because of normal processing time, but coverage can also be delayed if your initial claim is denied and your NordiCare® Case Manager is assisting with the appeal process.

If there will be a delay in getting insurance coverage, your Case Manager may talk with you about the JumpStart program, through which qualifying patients can receive a limited supply of free Norditropin®. You will never have to repay NordiCare® for this medication, even if your claim is eventually denied.a

JumpStart may still be an option even after your insurance coverage begins, if there is a risk of a gap in therapy caused by any of the following circumstances:


Moving


Changing insurance providers


Change in financial circumstances


Unexpected situations (such as losing the pen, the pen becoming too warm, etc.)


aPatients who have been prescribed Norditropin® for an FDA-approved indication, and who have commercial insurance may be eligible to receive a limited supply of free product from JumpStart. Patients who participate in any government, state, or federally funded medical or prescription benefit programs, including Medicare, Medicaid, Medigap, VA, DOD, and TRICARE, including patients who participate in a managed Medicaid program or have Medicaid as secondary insurance, are not eligible to participate in JumpStart. JumpStart product is provided at no cost to the patient or the HCP, is not contingent on any product purchase, and the patient and HCP must not: (1) bill any third party for the free product, or (2) resell the free product.

Patient Access Program

Patient Access Program

When money gets in the way.

Growth hormone is an important medical therapy. Lack of insurance coverage or limited financial means shouldn’t prevent someone from getting the treatment they need.If you qualify, our Patient Access Program is available to provide free Norditropin® for up to one (1) year to eligible patients who do not have adequate insurance coverage.

Patients who show true financial need based on things like their family’s yearly income, where they live, and the number of people living with them may receive this benefit until their financial or insurance status improves. To find out if you are eligible for help through NordiCare®, call us at 1-888-NOVO-444 (1-888-668-6444).b

bThe NordiCare® Norditropin® (somatropin injection) Patient Access Program (PAP) provides medication to qualifying applicants at no charge. If the applicant qualifies under the NordiCare® Norditropin® PAP guidelines, a 90-day supply of the requested medication(s) and applicable device(s) will be shipped to the patient. Patients who qualify for the PAP will be eligible to receive 90-day shipments, as prescribed, for up to 1 year from the approval date. Product is provided at no cost to the patient, is not contingent on any product purchase, and the patient must not: (1) bill any third-party for the free product, or (2) resell the free product.

NordiSure™

Because every little bit counts.

Whether or not your insurance covers Norditropin®, we know that costs can really add up. NordiSure is here to help.

NordiSure Co-pay Assistance Program
The NordiSure Co-pay Assistance Program can help eligible patients with the costs for Norditropin® by reducing your co-payments as much as $250 a month, up to $3,000 a year. For many patients, this may mean your entire cost is covered, depending on the specific insurance plan. There are no income or co-pay restrictions, nor is there a minimum payment amount.

NordiSure Coinsurance Program
This program is designed to help with high out-of-pocket prescription costs: you contribute a portion, and we contribute a portion. For patients with a co-pay of more than $1500 per month, the NordiSure Coinsurance Program will pay up to $4,000 a year; you are responsible for $75 per fill until the $4,000 maximum benefit is reached.

Contact your Case Manager at 1-888-NOVO-444 (1-888-668-6444) to determine whether you are eligible for NordiSure.c,d

cNordiSure Co-pay Assistance Program Terms and Conditions:
Card covers costs including but not limited to co-pay/coinsurance up to $250 per month of therapy for a period of 12 months to a maximum of $3,000 per year. Offer excludes full cash-paying customers. Patients must be enrolled in a commercial insurance plan. Card may be used for a maximum of 12 Norditropin® prescription fills. Card is not valid for prescriptions that are eligible to be reimbursed by private insurance plans or other health or pharmacy benefit programs that reimburse the patient for the entire cost of his or her prescription drugs. Not valid for prescriptions that are eligible to be reimbursed, in whole or in part, by Medicaid, Medicare (including Medicare Part D), or other Government funded or state programs (including any state prescription drug assistance programs and state health plans). The program cannot be combined with any other rebate/coupon, free trial, or similar offer for the specified prescription. Offer good only in the USA at participating pharmacies and cannot be redeemed at government-subsidized clinics. Void where taxed, restricted, or prohibited by law. Absent a change in Massachusetts law, effective July 1, 2019, the Savings Card will no longer be valid for residents of Massachusetts. Patient is responsible for complying with any insurance carrier co-payment disclosure requirements, including disclosing any savings received from this program. Re-confirmation of information may be requested periodically to ensure accuracy of data and compliance with terms. Participating patients must re-present their NordiSureSavings Card if changing pharmacies. This offer is limited to 1 card per patient. This card is not transferable. The NordiSure Savings Card may be used for mail order. Participating pharmacists must comply with all applicable laws and contractual or other obligations as a pharmacy provider. Participating patients and pharmacists understand and agree to comply with the terms and conditions of this offer as set forth herein. This is not an insurance program. Novo Nordisk reserves the right to rescind, revoke, or amend this offer without notice at any time. Non-medication expenses, such as ancillary supplies or administration-related costs, are not eligible. Must have a current prescription for an FDA approved indication.

dNordiSure Coinsurance Program Terms and Conditions:
Card covers costs including but not limited to co-pay/coinsurance to a maximum of $4000 per year of therapy. Offer excludes full cash-paying customers. Patients must be enrolled in a commercial insurance plan. Eligible patients must meet certain income requirements and have a co-pay greater than $1,500 toward which they must pay the first $75. Card may be used for a maximum of 12 Norditropin® prescription fills. Card is not valid for prescriptions that are eligible to be reimbursed by private insurance plans or other health or pharmacy benefit programs that reimburse the patient for the entire cost of his or her prescription drugs. Not valid for prescriptions that are eligible to be reimbursed, in whole or in part, by Medicaid, Medicare (including Medicare Part D), or other Government funded or state programs (including any state prescription drug assistance programs). The program cannot be combined with any other rebate/coupon, free trial, or similar offer for the specified prescription. Offer good only in the USA. USA at participating pharmacies and cannot be redeemed at government-subsidized clinics. Void where taxed, restricted, or prohibited by law. Absent a change in Massachusetts law, effective July 1, 2019, the Savings Card will no longer be valid for residents of Massachusetts. Patient is responsible for complying with any insurance carrier co-payment disclosure requirements, including disclosing any savings received from this program. Re-confirmation of information may be requested periodically to ensure accuracy of data and compliance with terms. Participating patients must re-present their NordiSure Savings Card if changing pharmacies. This offer is limited to 1 card per patient. This card is not transferable. The NordiSure Savings Card may be used for mail order. Participating pharmacists must comply with all applicable laws and contractual or other obligations as a pharmacy provider. Participating patients and pharmacists understand and agree to comply with the terms and conditions of this offer as set forth herein. This is not an insurance program. Novo Nordisk reserves the right to rescind, revoke, or amend this offer without notice at any time. Non-medication expenses, such as ancillary supplies or administration-related costs, are not eligible. Must have a current prescription for an FDA approved indication.

Selected Important Safety Information

Do not use Norditropin® if: you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing (respiratory) problems; you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea; you have cancer or other tumors; you are allergic to somatropin or any of the ingredients in Norditropin®; your healthcare provider tells you that you have certain types of eye problems caused by diabetes (diabetic retinopathy); you are a child with closed bone growth plates (epiphyses).

Indications and Usage

What is Norditropin® (somatropin) injection?
 
Norditropin® is a prescription medicine that contains human growth hormone and is used to treat:
  • children who are not growing because of low or no growth hormone 
  • children who are short (in stature) and who have Noonan syndrome, Turner syndrome, or were born small (small for gestational age-SGA) and have not caught-up in growth by age 2 to 4 years 
  • children who have Idiopathic Short Stature (ISS) 
  • children who are not growing who have Prader-Willi syndrome (PWS) 
  • adults who do not make enough growth hormone

Important Safety Information (cont’d)

Before taking Norditropin®, tell your healthcare provider about all of your medical conditions, including if you:

  • have had heart or stomach surgery, trauma or serious breathing (respiratory problems) 
  • have had a history of problems breathing while you sleep (sleep apnea) 
  • have or have had cancer or any tumor 
  • have diabetes 
  • are pregnant or breastfeeding, or plan to become pregnant or breastfeed

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Norditropin® may affect how other medicines work, and other medicines may affect how Norditropin® works.

How should I use Norditropin®?

  • Use Norditropin® exactly as your health care provider tells you to 
  • Do not share your Norditropin® pens and needles with another person even if the needle has been changed. You may give another person an infection or get an infection from them.

What are the possible side effects of Norditropin®?
Norditropin® may cause serious side effects, including:

  • high risk of death in people who have critical illnesses because of heart or stomach surgery, trauma or serious breathing (respiratory) problems 
  • high risk of sudden death in children with Prader-Willi syndrome who are severely obese or have breathing problems including sleep apnea 
  • increased risk of growth of cancer or a tumor that is already present and increased risk of the return of cancer or a tumor in people who were treated with radiation to the brain or head as children and who developed low growth hormone problems. Contact the healthcare provider if you or your child start to have headaches, or have changes in behavior, changes in vision, or changes in moles, birthmarks, or the color of your skin 
  • new or worsening high blood sugar (hyperglycemia) or diabetes 
  • increase in pressure in the skull (intracranial hypertension). If you or your child has headaches, eye problems, nausea or vomiting, contact the healthcare provider 
  • serious allergic reactions. Get medical help right away if you or your child has the following symptoms: swelling of your face, lips, mouth or tongue, trouble breathing, wheezing, severe itching, skin rashes, redness or swelling, dizziness or fainting, fast heartbeat or pounding in your chest, or sweating 
  • your body holding too much fluid (fluid retention) such as swelling in the hands and feet, pain in your joints or muscles or nerve problems that cause pain, burning, or tingling in the hands, arms, legs and feet. Tell your healthcare provider if you have any of these signs or symptoms of fluid retention. 
  • decrease in a hormone called cortisol. Tell your or your child’s healthcare provider if you or your child has darkening of the skin, severe fatigue, dizziness, weakness or weight loss 
  • decrease in thyroid hormone levels 
  • hip and knee pain or a limp in children (slipped capital femoral epiphysis) 
  • worsening of pre-existing curvature of the spine (scoliosis) 
  • severe and constant abdominal pain can be a sign of pancreatitis. Tell your or your child’s healthcare provider if you or your child has any new abdominal pain. 
  • loss of fat and tissue weakness in the area of skin you inject 
  • increase in phosphorus, alkaline phosphatase, and parathyroid hormone levels in your blood

The most common side effects of Norditropin® include:

  • injection site reactions and rashes, and headaches

Please click here for Norditropin® Prescribing Information.

Norditropin® is a prescription medication.

Novo Nordisk provides patient assistance for those who qualify. Please call 1-866-310-7549 to learn more about Novo Nordisk assistance programs.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800- FDA-1088.

Talk to your health care provider and find out if Norditropin® is right for you or your child.